{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T15:24:41Z","timestamp":1785165881663,"version":"3.55.0"},"reference-count":15,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":22,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000805","name":"European Centre for Disease Prevention and Control","doi-asserted-by":"publisher","award":["RS\/2022\/DTS\/2410"],"award-info":[{"award-number":["RS\/2022\/DTS\/2410"]}],"id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000805","name":"European Centre for Disease Prevention and Control","doi-asserted-by":"publisher","award":["RS\/2022\/DTS\/24104"],"award-info":[{"award-number":["RS\/2022\/DTS\/24104"]}],"id":[{"id":"10.13039\/501100000805","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Influenza Resp Viruses"],"published-print":{"date-parts":[[2024,4]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Using a common protocol across seven countries in the European Union\/European Economic Area, we estimated XBB.1.5 monovalent vaccine effectiveness (VE) against COVID\u201019 hospitalisation and death in booster\u2010eligible \u2265\u200965\u2010year\u2010olds, during October\u2013November 2023. We linked electronic records to construct retrospective cohorts and used Cox models to estimate adjusted hazard ratios and derive VE. VE for COVID\u201019 hospitalisation and death was, respectively, 67% (95%CI: 58\u201374) and 67% (95%CI: 42\u201381) in 65\u2010 to 79\u2010year\u2010olds and 66% (95%CI: 57\u201373) and 72% (95%CI: 51\u201385) in \u2265\u200980\u2010year\u2010olds. Results indicate that periodic vaccination of individuals \u2265\u200965\u2009years has an ongoing benefit and support current vaccination strategies in the EU\/EEA.<\/jats:p>","DOI":"10.1111\/irv.13292","type":"journal-article","created":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T01:00:13Z","timestamp":1713920413000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Effectiveness of XBB.1.5 Monovalent COVID\u201019 Vaccines During a Period of XBB.1.5 Dominance in EU\/EEA Countries, October to November 2023: A VEBIS\u2010EHR Network Study"],"prefix":"10.1111","volume":"18","author":[{"given":"Susana","family":"Monge","sequence":"first","affiliation":[{"name":"Department of Communicable Diseases, National Centre of Epidemiology Institute of Health Carlos III  Madrid Spain"},{"name":"CIBER on Infectious Diseases  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Humphreys","sequence":"additional","affiliation":[{"name":"Epiconcept  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Nicolay","sequence":"additional","affiliation":[{"name":"Vaccine Preventable Diseases and Immunisation European Centre for Disease Prevention and Control (ECDC)  Solna Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toon","family":"Braeye","sequence":"additional","affiliation":[{"name":"Sciensano  Elsene Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izaak","family":"Van\u00a0Evercooren","sequence":"additional","affiliation":[{"name":"Sciensano  Elsene Belgium"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Holm\u00a0Hansen","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology and Prevention Statens Serum Institut  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne\u2010Dorthe","family":"Emborg","sequence":"additional","affiliation":[{"name":"Department of Infectious Disease Epidemiology and Prevention Statens Serum Institut  Copenhagen Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Sacco","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department Istituto Superiore di Sanit\u00e0  Rome Italy"},{"name":"European Programme on Intervention Epidemiology Training (EPIET) European Centre for Disease Prevention and Control  Stockholm Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Mateo\u2010Urdiales","sequence":"additional","affiliation":[{"name":"Infectious Diseases Department Istituto Superiore di Sanit\u00e0  Rome Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6396-7265","authenticated-orcid":false,"given":"Jes\u00fas","family":"Castilla","sequence":"additional","affiliation":[{"name":"Instituto de Salud P\u00fablica de Navarra \u2013 IdiSNA  Pamplona Spain"},{"name":"CIBER on Epidemiology and Public Health  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Mart\u00ednez\u2010Baz","sequence":"additional","affiliation":[{"name":"Instituto de Salud P\u00fablica de Navarra \u2013 IdiSNA  Pamplona Spain"},{"name":"CIBER on Epidemiology and Public Health  Madrid Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9067-090X","authenticated-orcid":false,"given":"Brechje","family":"de Gier","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM)  Bilthoven The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hahn\u00e9","sequence":"additional","affiliation":[{"name":"Center for Infectious Disease Control National Institute for Public Health and the Environment (RIVM)  Bilthoven The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hinta","family":"Meijerink","sequence":"additional","affiliation":[{"name":"Norwegian Institute of Public Health (NIPH)  Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja\u00a0Br\u00e5then","family":"Kristoffersen","sequence":"additional","affiliation":[{"name":"Norwegian Institute of Public Health (NIPH)  Oslo Norway"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ausenda","family":"Machado","sequence":"additional","affiliation":[{"name":"Departamento de Epidemiologia Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge  Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Soares","sequence":"additional","affiliation":[{"name":"Departamento de Epidemiologia Instituto Nacional de Sa\u00fade Doutor Ricardo Jorge  Lisboa Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Nardone","sequence":"additional","affiliation":[{"name":"Epiconcept  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Bacci","sequence":"additional","affiliation":[{"name":"Vaccine Preventable Diseases and Immunisation European Centre for Disease Prevention and Control (ECDC)  Solna Sweden"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7188-8404","authenticated-orcid":false,"given":"Esther","family":"Kissling","sequence":"additional","affiliation":[{"name":"Epiconcept  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baltazar","family":"Nunes","sequence":"additional","affiliation":[{"name":"Epiconcept  Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"VEBIS\u2010EHR Working Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-075286","article-title":"Comparative Effectiveness of Bivalent BA.4\u20105 and BA.1 mRNA Booster Vaccines Among Adults Aged \u226550 Years in Nordic Countries: Nationwide Cohort Study","volume":"382","author":"Andersson N. W.","year":"2023","journal-title":"BMJ"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2024.29.3.2300708"},{"key":"e_1_2_9_4_1","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2807\/1560-7917.ES.2023.28.32.2300397","article-title":"Relative Effectiveness of Bivalent Original\/Omicron BA.4\u20105 mRNA Vaccine in Preventing Severe COVID\u201019 in Persons 60 Years and Above During SARS\u2010CoV\u20102 Omicron XBB.1.5 and Other XBB Sublineages Circulation, Italy, April to June 2023","volume":"28","author":"Fabiani M.","year":"2023","journal-title":"Eurosurveillance"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2024.29.1.2300670"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2022.27.37.2200697"},{"issue":"1","key":"e_1_2_9_7_1","article-title":"Early COVID\u201019 Vaccine Effectiveness of XBB.1.5 Vaccine Against Hospitalisation and Admission to Intensive Care, the Netherlands, 9 October to 5 December 2023","volume":"29","author":"Werkhoven C. H.","year":"2024","journal-title":"Eurosurveillance"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(23)00374-2"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2023.28.8.2300105"},{"key":"e_1_2_9_10_1","unstructured":"\u201cECDC\u2010EMA Statement on Updating COVID\u201019 Vaccines Composition for New SARS\u2010CoV\u20102 Virus Variants \u201d Emergency Task Force 7 June2023[Internet] accessed February 13 2024 https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/covid\u201019\u2010vaccines\u2010composition\u2010variants\u2010statement\u2010ECDC\u2010EMA_0.pdf."},{"key":"e_1_2_9_11_1","unstructured":"\u201cEuropean Respiratory Virus Surveillance Summary (ERVISS) [Internet]\u201d accessed February 13 2024 https:\/\/erviss.org\/."},{"key":"e_1_2_9_12_1","volume-title":"Pilot Protocol for a COVID\u201019 Vaccine Effectiveness Study Using Health Data Registries","author":"European Centre for Disease Prevention and Control","year":"2022"},{"key":"e_1_2_9_13_1","volume-title":"Protocol for a COVID\u201019 Vaccine Effectiveness Study Using Health Data Registries, v.2.0","author":"European Centre for Disease Prevention and Control","year":"2024"},{"key":"e_1_2_9_14_1","volume-title":"Protocol for a COVID\u201019 Vaccine Effectiveness Study Using Health Data Registries","author":"European Centre for Disease Prevention and Control","year":"2023"},{"key":"e_1_2_9_15_1","volume-title":"Interim Analysis of COVID\u201019 Vaccine Effectiveness against Hospitalisation and Death Using Electronic Health Records in Six European Countries","author":"European Centre for Disease Prevention and Control","year":"2023"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/sim.1186"}],"container-title":["Influenza and Other Respiratory Viruses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/irv.13292","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,26]],"date-time":"2024-04-26T00:30:24Z","timestamp":1714091424000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/irv.13292"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":15,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["10.1111\/irv.13292"],"URL":"https:\/\/doi.org\/10.1111\/irv.13292","archive":["Portico"],"relation":{"has-review":[{"id-type":"doi","id":"10.1111\/IRV.13292\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/IRV.13292\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/IRV.13292\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1111\/IRV.13292\/v2\/decision1","asserted-by":"object"}]},"ISSN":["1750-2640","1750-2659"],"issn-type":[{"value":"1750-2640","type":"print"},{"value":"1750-2659","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"2024-03-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-24","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-04-23","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e13292"}}